Kian M. Chang
Kuala Lumpur, Malaysia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Advanced Classical Hodgkin Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group.
Journal: JCO global oncology
Published: October 29, 2025
Peripheral T-Cell Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group.
Journal: JCO global oncology
Published: October 22, 2025
Baseline CD4+/CD8+ TEMRA Levels and Early Response Predict Survival After Umbilical Cord-Derived Mesenchymal Stem Cells Infusion in Acute GVHD Patients: A Randomized Double-Blinded Placebo-Controlled Multicentre Clinical Trial.
Journal: Journal of blood medicine
Published: June 12, 2025
Psychometric evaluation of Oral Mucositis Daily Questionnaire: A cross-cultural adaptation of the Malay version in multiethnic adult autologous stem cell transplant.
Journal: Asia-Pacific journal of oncology nursing
Published: November 01, 2022
Differential Regulation of NK Cell Receptors in Acute Lymphoblastic Leukemia.
Journal: Journal of immunology research
Published: January 21, 2022
Occult Disseminated Metastatic Breast Carcinoma Presenting as Acquired Thrombotic Thrombocytopenic Purpura.
Journal: Case reports in oncology
Published: November 11, 2021
Fluctuation of BCR-ABL1 qPCRIS level beyond 0.1%IS after stopping tyrosine kinase inhibitor in chronic myeloid leukaemia patients with deep molecular response for at least two years.
Journal: The Medical journal of Malaysia
Published: May 25, 2021
Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: October 12, 2020
Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response.
Journal: BMC cancer
Published: September 15, 2020
Reference interval establishment of full blood count extended research parameters in the multi-ethnic population of Malaysia.
Journal: The Medical journal of Malaysia
Published: January 14, 2020
Correction to: Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: December 08, 2019
Last Updated: 09/26/2026